Jane Street Group, LLC Sio Gene Therapies Inc. Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.28 - $0.41 $1,926 - $2,820	6,879 Added 7.44%	99,324 $28,000
Q2 2022 Aug 16, 2022	BUY	$0.25 - $0.73 $23,111 - $67,484	92,445 New	92,445 $33,000
Q1 2022 May 17, 2022	SELL	$0.55 - $1.47 $12,792 - $34,190	-23,259 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$1.29 - $2.36 $30,004 - $54,891	23,259 New	23,259 $30,000
Q1 2021 May 18, 2021	SELL	$2.34 - $3.44 $27,115 - $39,862	-11,588 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$1.91 - $5.63 $22,133 - $65,240	11,588 New	11,588 $32,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.